Ogugua Ndili Obi
Overview
Explore the profile of Ogugua Ndili Obi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Obi O, Polite P, Fish K, DeLuca R, Feustel P, Mandis A, et al.
Lung
. 2025 Jan;
203(1):31.
PMID: 39841245
Purpose: The priorities and concerns of sarcoidosis patients in the United States (US) have not been well-described. Methods: A survey constructed by sarcoidosis patients and doctors was administered to US...
2.
Obi O, Baughman R, Crouser E, Julian M, Locke L, Chandrasekaran A, et al.
ERJ Open Res
. 2025 Jan;
11(1.
PMID: 39811550
Background: In a phase 1b/2a clinical trial of efzofitimod in patients with corticosteroid-requiring pulmonary sarcoidosis, treatment resulted in dose-dependent improvement in key end-points. We undertook a analysis pooling dose arms...
3.
Wambui D, Kearney G, OBrien K, Iverson G, Obi O
N C Med J
. 2024 Oct;
85(4):274-282.
PMID: 39466100
Background: There is regional variability in sarcoidosis mortality across the United States. North Carolina ranks highly in sarcoidosis-related mortality, especially among African Americans (AA). We sought to determine any regional...
4.
Zhou Y, Jeny F, Vucinic V, Talwar D, Obi O, Judson M, et al.
Respir Med Res
. 2024 Jul;
86:101127.
PMID: 39084188
Background: The Sarcoidosis Diagnostic Score (SDS) system has been established for sarcoidosis patients based on the WASOG organ involvement criteria. We evaluated modifications of the SDS system to determine if...
5.
Obi O, Sharp M, Harper L
Curr Opin Pulm Med
. 2024 Jul;
30(5):551-560.
PMID: 38989780
Purpose Of Review: The impact of healthcare disparities in the treatment, care, and outcomes of patients with sarcoidosis has been described. There is paucity of literature on ways to address...
6.
Obi O, Saketkoo L, Maier L, Baughman R
J Autoimmun
. 2024 Mar;
149:103179.
PMID: 38548579
Sarcoidosis is a multi-organ granulomatous inflammatory disease of unknown etiology. Over 50% of patients will require treatment at some point in their disease and 10%-30% will develop a chronic progressive...
7.
Obi O
Clin Chest Med
. 2024 Jan;
45(1):131-157.
PMID: 38245362
Over 50% of patients with sarcoidosis will require anti-inflammatory therapy at some point in their disease course. Indications for therapy are to improve health-related quality of life, prevent or arrest...
8.
Obi O, Alqalyoobi S, Maddipati V, Lower E, Baughman R
Chest
. 2023 Oct;
165(4):892-907.
PMID: 37879560
Background: Different patterns of fibrosis on high-resolution CT scans (HRCT) have been associated with reduced survival in some interstitial lung diseases. Nothing is known about HRCT scan patterns and survival...
9.
Moor C, Obi O, Kahlmann V, Buschulte K, Wijsenbeek M
J Autoimmun
. 2023 Oct;
149:103123.
PMID: 37813805
Having sarcoidosis often has a major impact on quality of life of patients and their families. Improving quality of life is prioritized as most important treatment aim by many patients...
10.
Saketkoo L, Russell A, Patterson K, Obi O, Drent M
Curr Opin Pulm Med
. 2023 Jul;
29(5):501-511.
PMID: 37522560
Purpose Of Review: Sarcoidosis is a multiorgan system disease exerting significant impact on biophysical, social, psychological and emotional well-being. Mortality and disability correlate to accessible, timely, expert care for sarcoidosis...